A Premier Centre for Cutting Edge Cancer Research.
A dynamic research institute encompassing basic and translational studies, devoted to understanding the pathogenesis and treatment of cancer
Researchers from CSI Singapore & ASLAN Pharmaceuticals Make Headway in the Treatment of Acute Myeloid Leukemia (AML)
ASLAN003's potential for treating AML was discovered by research team from CSI Singapore and the National University Health System (NUHS).
Read More
Frontiers in Cancer Science 2019
Highlights from the 11th Frontiers in Cancer Science (FCS) conference which took place at The Academia @ SGH from 4 to 6 November 2019.
Read More
CSI Research Scientist Wins ASH Abstract Achievement Award
Congratulations to Dr. Zhou Jianbiao, Senior Research Scientist from Prof. Chng Wee Joo’s team, who has been awarded the American Society of Hematology (ASH) Abstract Achievement Award!
Read More
CSI Singapore Welcomes New Director, Professor Ashok Venkitaraman
The Cancer Science Institute of Singapore is pleased to announce the appointment of Professor Ashok Venkitaraman as the new Director of CSI Singapore.
Read More
CSI Graduate Recruitment 2019
On 8th October 2019, CSI Singapore hosted the Graduate Recruitment, which served as an excellent platform for participants to gain insights into the PhD program offered at CSI Singapore.
Read More
Frontiers in Cancer Science 2019
Learn more about our upcoming annual conference on CANCER RESEARCH Catalyst, the official blog of the American Association for Cancer Research (AACR).
Read More
Giving to CSI
You can help us to shape the next generation of innovative cancer research
